MedTrace Logo

A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits

NCT03192670 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2017-06-20

No results posted yet for this study

Summary

The primary objective of this study is to confirm and compare the effect of methods of Low-level light therapy (LED-T) in the mild cognitive impairment.

Conditions

Interventions

DEVICE

Low-level light therapy device

Peak wavelength:610nm, Power intensity: 1.7mW/cm2, Energy density: 2.0J/cm2, Skin-adhesive light-emitting probes: spot size, 1cm diameter

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER

  • Yong-il Shin, MD

    lead OTHER

Principal Investigators

  • Yong-il Shin, M.D, Ph.D · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192670 on ClinicalTrials.gov